P-111 PERSPECTIVE: Tepotinib plus cetuximab in patients with RAS/BRAF wild-type left-sided metastatic colorectal cancer and acquired resistance to anti-EGFR antibody therapy due to MET amplification

Conference Paper

Full Text

Published version (via Digital Object Identifier)

Duke Authors

Strickler, John

Cited Authors

Tabernero, J; Bekaii-Saab, T; Safont Aguilera, M; Cubillo, A; Garcia-Carbonero, R; Limon, L; Rodríguez-Salas, N; Tournigand, C; Borg, C; Raghav, K; Finley, G; Strickler, J; Beier, F; Salim, S; Esser, R; Liu, E; Adrian, S; López-López, C

Published Date

July 2021

Published In

Annals of Oncology

Volume / Issue

32 /

Start / End Page

S136 - S137

Published By

Elsevier BV

International Standard Serial Number (ISSN)

0923-7534

Digital Object Identifier (DOI)

10.1016/j.annonc.2021.05.166